(VUZI) Vuzix Cmn Stk - Overview
Stock: Smart Glasses, Waveguides, Display Engines, AR Software
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 106% |
| Relative Tail Risk | -8.71% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.10 |
| Alpha | -71.44 |
| Character TTM | |
|---|---|
| Beta | 2.275 |
| Beta Downside | 1.830 |
| Drawdowns 3y | |
|---|---|
| Max DD | 85.49% |
| CAGR/Max DD | -0.23 |
Description: VUZI Vuzix Cmn Stk January 02, 2026
Vuzix Corporation (NASDAQ: VUZI) develops and sells AI-enabled smart glasses, waveguide optics, and augmented-reality (AR) platforms across North America, Europe, APAC, and other international markets. Its product portfolio includes the M Series, Blade, Shield, and Z100 smart glasses, the Mobilium logistics software suite, and custom engineering services for ODM/OEM partners.
The company reaches customers through a mix of direct sales, value-added resellers, distributors, OEM partnerships, and online storefronts in the United States, Europe, and Japan, serving enterprise, industrial, medical, defense, security, and consumer segments.
Recent financials show Q1 2024 revenue of $19.2 million, a 14% year-over-year increase, and a cash balance of $71 million, giving it roughly 12 months of runway at current burn rates. The broader AR hardware market is projected to grow at a 38% CAGR through 2027, driven by enterprise adoption in logistics and field services-areas where Vuzix’s Mobilium platform has secured contracts with major distributors.
Key macro drivers include rising demand for hands-free workflow solutions in post-pandemic workplaces and increased defense spending on wearable situational-awareness gear, both of which align with Vuzix’s product roadmap.
For a deeper quantitative assessment, you might explore ValueRay’s detailed analyst dashboard.
Piotroski VR‑10 (Strict, 0-10) 0.0
| Net Income: -37.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.46 > 0.02 and ΔFCF/TA 28.48 > 1.0 |
| NWC/Revenue: 457.2% < 20% (prev 478.1%; Δ -20.93% < -1%) |
| CFO/TA -0.41 > 3% & CFO -17.3m > Net Income -37.3m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 7.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (77.5m) vs 12m ago 14.20% < -2% |
| Gross Margin: -113.5% > 18% (prev -0.82%; Δ -11.3k% > 0.5%) |
| Asset Turnover: 12.59% > 50% (prev 13.26%; Δ -0.67% > 0%) |
| Interest Coverage Ratio: -105.0 > 6 (EBITDA TTM -34.7m / Interest Expense TTM -358.7k) |
Altman Z'' -15.00
| A: 0.57 (Total Current Assets 28.2m - Total Current Liabilities 3.95m) / Total Assets 42.5m |
| B: -9.21 (Retained Earnings -391.2m / Total Assets 42.5m) |
| C: -0.89 (EBIT TTM -37.7m / Avg Total Assets 42.2m) |
| D: -85.25 (Book Value of Equity -391.1m / Total Liabilities 4.59m) |
| Altman-Z'' Score: -121.8 = D |
Beneish M -3.98
| DSRI: 0.48 (Receivables 1.46m/3.17m, Revenue 5.31m/5.55m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.98 (AQ_t 0.11 / AQ_t-1 0.11) |
| SGI: 0.96 (Revenue 5.31m / 5.55m) |
| TATA: -0.47 (NI -37.3m - CFO -17.3m) / TA 42.5m) |
| Beneish M-Score: -3.98 (Cap -4..+1) = AAA |
What is the price of VUZI shares?
Over the past week, the price has changed by -4.56%, over one month by -28.49%, over three months by -11.93% and over the past year by -41.22%.
Is VUZI a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the VUZI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 3 | 19.5% |
| Analysts Target Price | 3 | 19.5% |
| ValueRay Target Price | 2.1 | -15.5% |
VUZI Fundamental Data Overview February 03, 2026
P/B = 7.5571
Revenue TTM = 5.31m USD
EBIT TTM = -37.7m USD
EBITDA TTM = -34.7m USD
Long Term Debt = 1.13m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 500.9k USD (from shortTermDebt, last quarter)
Debt = 1.13m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -21.5m USD (from netDebt column, last quarter)
Enterprise Value = 189.3m USD (210.7m + Debt 1.13m - CCE 22.6m)
Interest Coverage Ratio = -105.0 (Ebit TTM -37.7m / Interest Expense TTM -358.7k)
EV/FCF = -9.63x (Enterprise Value 189.3m / FCF TTM -19.7m)
FCF Yield = -10.38% (FCF TTM -19.7m / Enterprise Value 189.3m)
FCF Margin = -370.1% (FCF TTM -19.7m / Revenue TTM 5.31m)
Net Margin = -702.7% (Net Income TTM -37.3m / Revenue TTM 5.31m)
Gross Margin = -113.5% ((Revenue TTM 5.31m - Cost of Revenue TTM 11.3m) / Revenue TTM)
Gross Margin QoQ = -35.43% (prev -58.76%)
Tobins Q-Ratio = 4.46 (Enterprise Value 189.3m / Total Assets 42.5m)
Interest Expense / Debt = 59.68% (Interest Expense 676.8k / Debt 1.13m)
Taxrate = 21.0% (US default 21%)
NOPAT = -29.8m (EBIT -37.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 7.14 (Total Current Assets 28.2m / Total Current Liabilities 3.95m)
Debt / Equity = 0.03 (Debt 1.13m / totalStockholderEquity, last quarter 37.9m)
Debt / EBITDA = 0.62 (negative EBITDA) (Net Debt -21.5m / EBITDA -34.7m)
Debt / FCF = 1.09 (negative FCF - burning cash) (Net Debt -21.5m / FCF TTM -19.7m)
Total Stockholder Equity = 35.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -88.51% (Net Income -37.3m / Total Assets 42.5m)
RoE = -105.2% (Net Income TTM -37.3m / Total Stockholder Equity 35.5m)
RoCE = -102.9% (out of range, set to none) (EBIT -37.7m / Capital Employed (Equity 35.5m + L.T.Debt 1.13m))
RoIC = -93.82% (negative operating profit) (NOPAT -29.8m / Invested Capital 31.7m)
WACC = 14.22% (E(210.7m)/V(211.9m) * Re(14.30%) + (debt cost/tax rate unavailable))
Discount Rate = 14.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 9.41%
Fair Price DCF = unknown (Cash Flow -19.7m)
EPS Correlation: 18.28 | EPS CAGR: 8.03% | SUE: 0.61 | # QB: 0
Revenue Correlation: -68.00 | Revenue CAGR: -24.40% | SUE: -0.43 | # QB: 0
EPS next Year (2026-12-31): EPS=-0.36 | Chg30d=+0.020 | Revisions Net=+1 | Growth EPS=+10.0% | Growth Revenue=+110.0%